My PCR
Create Account
Logo PCR

24 Nov 2024

Tricuspid / Pulmonary valve

Featured research - Tricuspid valve (Part 1)

Session comprising selected PCR London Valves 2024 Abstracts submissions

Facilitators: N. Schofer, Y. Topilsky
Speakers: J. C. Echarte Morales, M. Kassar, L. Badano, M. Gerçek, C. Iliadis, M. Paukovitsch

Summary

Explore the latest research on tricuspid valve interventions in this featured session from PCR London Valves 2024. Discover insights on the prognostic impact of heart failure hospitalization in severe tricuspid regurgitation, the influence of moderate mitral regurgitation in tricuspid TEER patients, the association of effective right ventricle EF with outcomes in secondary tricuspid regurgitation, and optimization of transcatheter tricuspid annuloplasty. Additionally, gain knowledge on redo T-TEER and the impact of tricuspid edge-to-edge repair beyond leaflet approximation.

Presentations available when logged in:

  • Prognostic impact of heart failure hospitalisation in patients with severe tricuspid regurgitation undergoing TEER
  • Impact of moderate MR in patients with severe TR undergoing tricuspid TEER
  • Association of effective right ventricle EF with outcomes in patients with secondary tricuspid regurgitation
  • Optimising transcatheter tricuspid annuloplasty by patient selection and procedural approach
  • Redo T-TEER for severe tricuspid regurgitation after prior surgical or interventional treatment
  • Tricuspid edge-to-edge repair leads to significant annuloplasty beyond leaflet approximation
Related Content
Tricuspid, mitral and structural innovations Retrievals, foreign bodies and entrapments Your journey through PCR London Valves 2025 starts here
Recommended for you
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines Take the stage at EuroPCR PCR Tokyo Valves 2026: What's on the Programme?